We are live on ! Find out more
AI

Alphabet Inc Portfolio holdings

AUM $4.02B
1-Year Est. Return 215.74%
This Fund
S&P 500
This Quarter Est. Return
+0.01%
1 Year Est. Return
+215.74%
3 Year Est. Return
+350.01%
5 Year Est. Return
+242.03%
10 Year Est. Return
+998.87%
AUM
$1.84B
AUM Growth
-$132M
Cap. Flow
-$56M
Cap. Flow %
-3.04%
Top 10 Hldgs %
90.16%
Holding
43
New
1
Increased
1
Reduced
3
Closed
1

Top Buys

Rank Stock Value
1
FRSH icon
Freshworks
FRSH
+$46.4M
2
WGS icon
GeneDx Holdings
WGS
+$767K

Top Sells

Rank Stock Value
1
SNOW icon
Snowflake
SNOW
+$51.8M
2
RVMD icon
Revolution Medicines
RVMD
+$45.8M
3
ILMN icon
Illumina
ILMN
+$5.58M
4
BHIL
Benson Hill, Inc.
BHIL
+$6

Sector Composition

Rank Sector Weight
1 Technology 64.74%
2 Healthcare 30.94%
3 Industrials 4.15%
4 Consumer Staples 0.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GTLB icon
1
GitLab
GTLB
$5.28B
$503M 27.3%
9,758,333
– –
ARM icon
2
Arm
ARM
$278B
$280M 15.22%
1,960,784
– –
RVMD icon
3
Revolution Medicines
RVMD
$40.2B
$193M 10.48%
4,256,175
-1,050,900
-20% -$45.8M
FRSH icon
4
Freshworks
FRSH
$2.84B
$186M 10.1%
16,206,643
+3,870,000
+31% +$46.4M
CRWD icon
5
CrowdStrike
CRWD
$187B
$120M 6.52%
1,711,580
– –
PATH icon
6
UiPath
PATH
$5.62B
$90M 4.89%
7,034,337
– –
TEM
7
Tempus AI
TEM
$7.69B
$87.8M 4.77%
1,551,102
– –
PL icon
8
Planet Labs
PL
$7.3B
$71.2M 3.87%
31,942,641
– –
DXCM icon
9
DexCom
DXCM
$27.6B
$69.5M 3.77%
1,036,937
– –
VERV
10
DELISTED
Verve Therapeutics
VERV
$59.8M 3.24%
12,349,086
– –
PRME icon
11
Prime Medicine
PRME
$533M
$58.3M 3.16%
15,062,498
– –
SNOW icon
12
Snowflake
SNOW
$92.9B
$13.2M 0.71%
114,554
-421,050
-79% -$51.8M
SANA icon
13
Sana Biotechnology
SANA
$885M
$11.7M 0.64%
2,812,500
– –
RLAY icon
14
Relay Therapeutics
RLAY
$4.02B
$11.1M 0.6%
1,568,753
– –
VERA icon
15
Vera Therapeutics
VERA
$2.54B
$10.7M 0.58%
241,264
– –
OSCR icon
16
Oscar Health
OSCR
$8.5B
$10.2M 0.56%
481,988
– –
LYEL icon
17
Lyell Immunopharma
LYEL
$309M
$8.09M 0.44%
293,256
– –
BEAM icon
18
Beam Therapeutics
BEAM
$2.58B
$7.88M 0.43%
321,604
– –
GLUE icon
19
Monte Rosa Therapeutics
GLUE
$1.92B
$7.76M 0.42%
1,464,015
– –
DNTH icon
20
Dianthus Therapeutics
DNTH
$5.68B
$5.71M 0.31%
208,697
– –
TCRX icon
21
TScan Therapeutics
TCRX
$51.9M
$5.36M 0.29%
1,077,080
– –
DM
22
DELISTED
Desktop Metal, Inc.
DM
$5.16M 0.28%
1,104,871
– –
FHTX icon
23
Foghorn Therapeutics
FHTX
$285M
$4.66M 0.25%
500,901
– –
BHIL
24
DELISTED
Benson Hill, Inc.
BHIL
$3.16M 0.17%
438,635
-1
-0% -$6
AUTL
25
Autolus Therapeutics
AUTL
$386M
$2.53M 0.14%
698,262
– –
1
2

Similar funds

JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
MGP
Metis Global Partners San Diego, California $4.07B AUM 30.82% 1-Year Est. Return

Alphabet Inc's Q3 2024 Portfolio in Review

As of Q3 2024, Alphabet Inc held 43 positions worth $1.84B, down 6.7% from $1.97B the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Alphabet Inc withdrew a net $56M in Q3 2024, closing 1 position and reducing 3 holdings. Its most notable exit was Illumina, an estimated $5.58M position sold in full.

By sector, the portfolio is most concentrated in Technology at 65% of assets, down from 65% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Alphabet Inc opened a new position in GeneDx Holdings worth $964K.

  • Alphabet Inc's largest Q3 2024 buy was GeneDx Holdings: 22,711 shares worth $964K.
  • Alphabet Inc added most to Freshworks in Q3 2024, an estimated $46.4M increase.
  • Alphabet Inc's biggest Q3 2024 reduction was Snowflake, cutting an estimated $51.8M.
  • Alphabet Inc fully exited Illumina in Q3 2024, selling an estimated $5.58M.
  • Alphabet Inc's ten largest holdings make up 90% of its $1.84B portfolio in Q3 2024.
  • Alphabet Inc opened 1 new position and closed 1 in Q3 2024.
  • Alphabet Inc's portfolio value fell 6.7% quarter-over-quarter to $1.84B.

Based on Alphabet Inc's 13F filing for Q3 2024, filed 8 Nov 2024.